Ascendis Pharma (ASND) PT Raised to $333 at Jefferies

August 13, 2026 4:03 PM

Jefferies analyst Kelly Shi raised the price target on Ascendis Pharma (NASDAQ: ASND) to $333.00 (from $325.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found